Jennifer A. Kricker

Reykjavik, 102, Iceland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

The Effect of the Novel Macrolide Glasmacinal (EP395) on Allergen-Induced Eosinophil Infiltration into the Lung.

The Effect of the Novel Macrolide Glasmacinal (EP395) on Allergen-Induced Eosinophil Infiltration into the Lung.

Journal: Lung

Published: February 19, 2026

In Vitro and In Vivo Efficacy of Epithelial Barrier-Promoting Barriolides as Potential Therapy for Ulcerative Colitis.

In Vitro and In Vivo Efficacy of Epithelial Barrier-Promoting Barriolides as Potential Therapy for Ulcerative Colitis.

Journal: Biomedicines

Published: December 01, 2025

Impact of the anti-inflammatory macrolide glasmacinal on the gut microbiota of healthy adults: an open-label trial.

Impact of the anti-inflammatory macrolide glasmacinal on the gut microbiota of healthy adults: an open-label trial.

Journal: Nature communications

Published: November 15, 2025

Promoting immune defensive responses of epithelial cells in airway disease.

Promoting immune defensive responses of epithelial cells in airway disease.

Journal: Frontiers in allergy

Published: September 02, 2025

The Non-Antibacterial Effects of Azithromycin and Other Macrolides on the Bronchial Epithelial Barrier and Cellular Differentiation.

The Non-Antibacterial Effects of Azithromycin and Other Macrolides on the Bronchial Epithelial Barrier and Cellular Differentiation.

Journal: International journal of molecular sciences

Published: February 04, 2025

Effect of EP395, a novel anti-inflammatory macrolide, in an inhaled lipopolysaccharide challenge model in healthy volunteers: a randomised controlled trial.

Effect of EP395, a novel anti-inflammatory macrolide, in an inhaled lipopolysaccharide challenge model in healthy volunteers: a randomised controlled trial.

Journal: Pulmonary pharmacology & therapeutics

Published: February 03, 2025

Effects of EP395, a novel macrolide, on acute neutrophilic airway inflammation.

Effects of EP395, a novel macrolide, on acute neutrophilic airway inflammation.

Journal: Pulmonary pharmacology & therapeutics

Published: January 09, 2025

A novel macrolide, EP395, with reduced antibacterial activity and an enhancing effect on respiratory epithelial barrier.

A novel macrolide, EP395, with reduced antibacterial activity and an enhancing effect on respiratory epithelial barrier.

Journal: Pulmonary pharmacology & therapeutics

Published: January 08, 2025

Prospects for macrolide therapy of asthma and COPD.

Prospects for macrolide therapy of asthma and COPD.

Journal: Advances in pharmacology (San Diego, Calif.)

Published: July 31, 2023

Ventilator-induced lung injury results in oxidative stress response and mitochondrial swelling in a mouse model.

Ventilator-induced lung injury results in oxidative stress response and mitochondrial swelling in a mouse model.

Journal: Laboratory animal research

Published: April 22, 2022

Factors Determining Plasticity of Responses to Drugs.

Factors Determining Plasticity of Responses to Drugs.

Journal: International journal of molecular sciences

Published: January 05, 2022

Nonantimicrobial Actions of Macrolides: Overview and Perspectives for Future Development.

Nonantimicrobial Actions of Macrolides: Overview and Perspectives for Future Development.

Journal: Pharmacological reviews

Published: October 30, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026